News Conference News TCT 2024 TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation Michael O'Riordan October 30, 2024
News Conference News TCT 2024 TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR Michael O'Riordan October 29, 2024
Presentation TCT 2022 FDA Update on EFS Requirements for TTVR Technologies Presenter: Kevin G. Soucy September 17, 2022